Are we ready for targeted early breast cancer detection strategies in women with NF1 aged 30-49 years?

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 12, 2012, Pages 3054-3055

  Evans, D Gareth ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BREAST BIOPSY; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL PROTOCOL; EARLY CANCER; FAMILY HISTORY; FEMALE; HUMAN; MAMMOGRAPHY; NATIONAL HEALTH SERVICE; NEUROFIBROMATOSIS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; UNITED KINGDOM;

EID: 84870239558     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35585     Document Type: Note

References (11)

1. Evans DG, Howard E, Wilding A, Ingham SL, Moran A, Scott-Kitching V, Holt F, Huson SM. 2011. Mortality in neurofibromatosis 1. Eur J Hum Genet 19: 1187-1191.
2. Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, Gilbert FJ, Griebsch I, Hoff RJ, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon LJ, Thompson D, Warren RM, MARIBS Study Group. 2005. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 365: 1769-1778.
3. Madanikia SA, Bergner A, Ye X, Blakeley JO. 2012. Increased risk of breast cancer in women with NF1. Am J Med Genet.
4. McIntosh A, Shaw C, Evans G, Turnbull N, Bahar N, Barclay M, Easton D, Emery J, Gray J, Halpin J, Hopwood P, McKay J, Sheppard C, Sibbering M, Watson W, Wailoo A, Hutchinson A. 2006. (2004 updated 2006) Clinical Guidelines and Evidence Review for The Classification and Care of Women at Risk of Familial Breast Cancer, London: National Collaborating Centre for Primary Care/University of Sheffield. NICE guideline CG041. www.nice.org.uk.
5. Rasmussen SA, Yang Q, Friedman JM. 2001. Mortality in neurofibromatosis 1: An analysis using U.S. death certificate. Am J Hum Genet 68: 1110-1118.
6. Sharif S, Ferner R, Birch J, Gattamaneni R, Gillespie J, Evans DGR. 2006. Second primary tumours in neurofibromatosis 1 (NF1) patients treated for optic glioma: Substantial risks post radiotherapy. J Clin Oncol 24: 2570-2575.
7. Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Evans DGR. 2007. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44: 481-484.
8. Sørensen SA, Mulvihill JJ, Nielsen A. 1986. Long-term follow-up of von Recklinghausen neurofibromatosis-Survival and malignant neoplasms. N Engl J Med 314: 1010-1015.
9. US Preventive Services Task Force. 2009. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 151: 716-726 W-236.
10. Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, Baralle D. 2006. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 95: 233-238.
11. Wang X, Levin AM, Smolinski SE, Vigneau FD, Levin NK, Tainsky MA. 2012. Breast cancer and other neoplasias in women with neurofibromatosis type 1: A retrospective review of cases in the detroit metropolitan area. Am J Med Genet.